Spherix Incorporated engages in the research, development, and commercialization of products primarily for the treatment of Type 2 diabetes. Its principal product includes Naturlose, which is in Phase III clinical trials for the treatment for Type 2 diabetes. Naturlose is the brand name for tagatose, a naturally occurring ketose that is found in dairy products and other foods. The company focuses on the usage of Naturlose as a low-calorie and full-bulk sweetener in various natural and safe products, including cosmetics, toothpaste, mouthwash, over-the-counter drugs, and prescription medications. Spherix Incorporated has a license agreement with Arla Foods Ingredients amba to manufacture, market, and distribute tagatose as a food and beverage ingredient. The company was founded in 1967 and is headquartered in Beltsville, Maryland.